LianBio Market Cap

LianBio has a market cap or net worth of $31.15 million as of April 23, 2024. Its market cap has decreased by -81.80% in one year.

Market Cap

31.15M

Enterprise Value

-219.10M

1-Year Change

-81.80%

Ranking

n/a

Market Cap Chart

Since the IPO on November 1, 2021, LianBio's market cap has decreased from $1.68B to $31.15M, a decrease of -98.15%. That is a compound annual growth rate of -81.32%.

Market Cap History

Date	Market Cap	% Change
Mar 18, 2024	34.50M	-8.24%
Mar 15, 2024	37.60M	-93.03%
Mar 14, 2024	539.20M	0.80%
Mar 13, 2024	534.90M	-
Mar 12, 2024	534.90M	0.60%
Mar 11, 2024	531.70M	-0.19%
Mar 8, 2024	532.70M	0.60%
Mar 7, 2024	529.50M	-0.81%
Mar 6, 2024	533.80M	0.39%
Mar 5, 2024	531.70M	0.62%
Mar 4, 2024	528.40M	0.21%
Mar 1, 2024	527.30M	0.82%
Feb 29, 2024	523.00M	0.40%
Feb 28, 2024	520.90M	0.12%
Feb 27, 2024	520.30M	0.10%
Feb 26, 2024	519.80M	0.43%
Feb 23, 2024	517.60M	-
Feb 22, 2024	517.60M	-
Feb 21, 2024	517.60M	-
Feb 20, 2024	517.60M	0.41%
Feb 16, 2024	515.50M	-0.19%
Feb 15, 2024	516.50M	0.41%
Feb 14, 2024	514.40M	-0.83%
Feb 13, 2024	518.70M	18.80%
Feb 12, 2024	436.60M	-2.41%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	709.13B
Novo Nordisk	559.76B
UnitedHealth Group	448.47B
Johnson & Johnson	360.36B
Merck & Co.	321.39B
AbbVie	300.16B
AstraZeneca	219.62B
Thermo Fisher	219.52B

Market Cap Rankings